Expanding the Reach of Lung Cancer Screening: Risk Models for Individuals Who Never Smoked

Affiliations

Editorial

Anil Vachani et al. Am J Respir Crit Care Med. 2023.

. 2023 Jan 1;207(1):13-15.

doi: 10.1164/rccm.202208-1521ED.

No abstract available

Comment on

Risk-stratified Approach for Never- and Ever-Smokers in Lung Cancer Screening: A Prospective Cohort Study in China.
Wang F, Tan F, Shen S, Wu Z, Cao W, Yu Y, Dong X, Xia C, Tang W, Xu Y, Qin C, Zhu M, Li J, Yang Z, Zheng Y, Luo Z, Zhao L, Li J, Ren J, Shi J, Huang Y, Wu N, Shen H, Chen W, Li N, He J. Wang F, et al. Am J Respir Crit Care Med. 2023 Jan 1;207(1):77-88. doi: 10.1164/rccm.202204-0727OC. Am J Respir Crit Care Med. 2023. PMID: 35900139

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2021;71:209–249. - PubMed
1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med . 2011;365:395–409. - PMC - PubMed
1. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med . 2020;382:503–513. - PubMed
1. Chien L-H, Chen C-H, Chen T-Y, Chang G-C, Tsai Y-H, Hsiao C-F, et al. Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model. Cancer Epidemiol Biomarkers Prev . 2020;29:452–459. - PubMed
1. Yano T, Miura N, Takenaka T, Haro A, Okazaki H, Ohba T, et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer. 2008;113:1012–1018. - PubMed